Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Obesity is a leading global public health crisis
Please enter your ID number to validate your DStv Subscription.
Moreover, they also have a positive effect on cardiometabolic risk factors most probably translating to a moderate reduction in the risk of major adverse cardiovascular events that still remain undetermined
Incretin triple agonist retatrutide (LY3437943) alleviates obesity-associated cancer progression
The buzz around GLP-1 medications has moved well beyond Hollywood
US Market Access Strategy Consulting Payer Control Shapes the Market The evolution of payer control in the GLP-1 space across different indications and products highlights the impact of specific indications and product strategy on patient access
US$ 29.03
US$ 29.49
US$ 25.64
US$ 27.91
US$ 25.68
